SARAH GRAY: Open Payments
NPI 1043871866 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 38 payments from 18 companies in 2025. Trend: 2023 $1,272 · 2024 $1,028 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 4 | $285 |
| AstraZeneca Pharmaceuticals LP | 8 | $221 |
| PFIZER INC. | 3 | $56 |
| Antares Pharma, Inc. | 2 | $48 |
| Esperion Therapeutics, Inc. | 2 | $47 |
| Amgen Inc. | 3 | $44 |
| ViiV Healthcare Company | 2 | $42 |
| ABBVIE INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Novo Nordisk Inc | 2 | $30 |
Products named: BREZTRI, FARXIGA, AIRSUPRA, ELIQUIS, XYOSTED, NEXLETOL, APRETUDE, ULTOMIRIS.
Industry payments across NC — which companies pay providers there.
